Donald Deieso

Donald Allan Deieso founded WIRB- Copernicus Group, Inc. in 2012, where he worked as Executive Chairman & Chief Executive Officer from 2012 to 2022.
Dr. Deieso also currently works at TractManager, Inc., as Chairman from 2015, WCG IRB, Inc., as Chairman & President, ClinicaHealth, Inc., as Director, Steamboat IS, Inc., as Director, BioIVT LLC, as Director, Sera Laboratories International Ltd., as Director from 2016, In Vitro GmbH, as Co-Managing Director, and WCG Clinical Services, Inc., as President & Director.
Dr. Deieso also formerly worked at Metcalf & Eddy, as President & Chief Executive Officer, Kaplan EduNeering, Inc., as President & Chief Executive Officer, PeriGen, Inc., as Chairman & Chief Executive Officer, WCG Clinical, Inc., as Executive Chairman & Chief Executive Officer, MediTract, Inc., as Chairman, Certara USA, Inc., as Chairman, Synthace Ltd., as Chairman from 2022 to 2024, Global Safety Surveillance, Inc., as Director, Innovative Medical Device Solutions, LLC, as Director, Certara UK Ltd., as Secretary & Director from 2013 to 2017, Breckenridge Financial Services, as Director, Consolidated Edison Company of New York, Inc., as Principal, Arsenal Capital Management LP, as Senior Advisor, The Copernicus Group, Inc., as President, Kenan Institute, as Member, New Jersey Symphony Orchestra, as Trustee, and The University of North Carolina at Charlotte, as Trustee.
Dr. Deieso received his graduate degree and doctorate degree from Rutgers State University of New Jersey and undergraduate degree from Manhattan College.